Search

everythinglearnresearchcommunity

for

Search:↓

Using a special gel with copper and curcumin along with a scraping massage technique improved hair growth better than the common hair loss treatment, minoxidil.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Exposure to Corexit dispersants during the oil spill cleanup was linked to increased respiratory and eye irritation symptoms in workers.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The B2C promoter works in sheep cells but not in mouse embryos.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

circCFAP20DC helps goat ovarian cells grow, aiding follicle development.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

CGF and i-PRF are more effective and safer than PRP for treating female pattern hair loss.

Small bowel lesions in Cronkhite-Canada syndrome persist despite steroid treatment.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

A new method was developed to grow and maintain human hair follicle stem cells for hair reconstruction.

A U.S. Naval fighter pilot suffered permanent vision loss in one eye due to recurrent central serous retinopathy.

Researchers developed a cost-effective 66 K SNP chip for cashmere goats that is accurate and useful for genetic studies.

New instruments were introduced to make hair transplantation surgery more precise and improve graft survival.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

SIG-1451 could be a promising new treatment for atopic dermatitis.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Certain genetic variants impair enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

The document's conclusion cannot be summarized because the content is not available.

The JCCP's Premises Standards aim to make non-surgical cosmetic treatments safer and higher quality.